Seth Love Selected Research

Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)

1/2021	Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease.
6/2015	Synaptic protein levels altered in vascular dementia.
6/2015	Investigation of Aβ phosphorylated at serine 8 (pAβ) in Alzheimer's disease, dementia with Lewy bodies and vascular dementia.
4/2015	Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia.
5/2014	Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia.
7/2013	Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins.
7/2012	Assessment of activation of the plasma kallikrein-kinin system in frontal and temporal cortex in Alzheimer's disease and vascular dementia.
12/2010	Kallikrein-related peptidase 6 in Alzheimer's disease and vascular dementia.
10/2010	Plasminogen and plasmin in Alzheimer's disease.
7/2009	Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seth Love Research Topics

Disease

90	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2003
26	Dementia (Dementias) 01/2022 - 11/2007
18	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2022 - 08/2003
10	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2021 - 07/2009
7	Neuroblastoma 01/2017 - 07/2009
5	Parkinson Disease (Parkinson's Disease) 01/2022 - 05/2003
5	Inflammation (Inflammations) 12/2020 - 07/2004
5	Hypertension (High Blood Pressure) 01/2020 - 01/2008
5	Amyloid Plaque 01/2020 - 06/2005
4	Cognitive Dysfunction 02/2021 - 11/2011
4	Hypoxia (Hypoxemia) 01/2021 - 04/2015
4	Necrosis 01/2021 - 06/2007
4	Multiple Sclerosis 05/2012 - 01/2008
3	Hallucinations (Hallucination) 01/2022 - 08/2015
3	Disease Progression 01/2021 - 01/2009
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020 - 02/2013
3	Neoplasms (Cancer) 12/2015 - 04/2002
3	Demyelinating Diseases (Demyelinating Disease) 02/2013 - 01/2008
2	Thrombosis (Thrombus) 01/2022 - 12/2020
2	Infections 01/2021 - 01/2018
2	Lewy Body Disease (Lewy Body Dementia) 12/2020 - 01/2017
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 10/2020 - 03/2008
2	Central Nervous System Vasculitis 10/2020 - 03/2005
2	Frontotemporal Dementia (Semantic Dementia) 08/2015 - 09/2014
2	Parkinsonian Disorders (Parkinsonism) 08/2015 - 09/2014
2	Ischemia 01/2014 - 07/2013
2	Rupture 01/2013 - 09/2012
2	Multiple System Atrophy 11/2007 - 01/2003
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2022
1	Mixed Dementias 01/2021

Drug/Important Bio-Agent (IBA)

31	Amyloid (Amyloid Fibrils)IBA 11/2022 - 03/2005
27	Proteins (Proteins, Gene)FDA Link 12/2019 - 04/2002
16	Amyloid beta-PeptidesIBA 11/2018 - 01/2004
14	Apolipoproteins E (ApoE)IBA 01/2022 - 08/2003
13	EnzymesIBA 01/2016 - 03/2008
10	Neprilysin (Neutral Endopeptidase)IBA 01/2016 - 10/2006
9	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2020 - 01/2009
9	Peptides (Polypeptides)IBA 11/2018 - 01/2009
8	Endothelin-1 (Endothelin 1)IBA 01/2021 - 01/2012
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 07/2014
6	SynucleinsIBA 12/2020 - 01/2014
5	Biomarkers (Surrogate Marker)IBA 02/2021 - 01/2012
5	Endothelins (Endothelin)IBA 01/2021 - 07/2009
5	Myelin-Associated GlycoproteinIBA 01/2021 - 07/2013
5	CytokinesIBA 01/2021 - 11/2006
4	Vasoconstrictor AgentsIBA 01/2021 - 04/2015
4	Biological ProductsIBA 12/2020 - 06/2007
4	Insulysin (Insulin-Degrading Enzyme)IBA 01/2016 - 06/2005
4	ParaffinIBA 07/2013 - 04/2002
3	AngiotensinsIBA 12/2020 - 12/2009
3	AN-1792IBA 01/2018 - 07/2008
3	SynaptophysinIBA 01/2018 - 06/2015
3	Endothelin-Converting EnzymesIBA 01/2017 - 11/2011
3	Angiotensin IIIBA 01/2016 - 02/2011
3	ImmunosorbentsIBA 06/2015 - 07/2009
3	Myelin ProteinsIBA 01/2015 - 07/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2012 - 01/2008
3	Messenger RNA (mRNA)IBA 01/2012 - 07/2009
3	Transforming Growth Factor beta (TGF-beta)IBA 11/2007 - 07/2004
2	IronIBA 01/2022 - 01/2014
2	Cholinergic Agents (Cholinergics)IBA 01/2022 - 12/2019
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 11/2004
2	AD 20 (AD-20)IBA 01/2021 - 10/2010
2	Interleukin-5 (Interleukin 5)IBA 01/2021 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2018
2	Interleukin-16 (Interleukin 16)IBA 01/2021 - 01/2018
2	Interleukin-15 (Interleukin 15)IBA 01/2021 - 01/2018
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 11/2006
2	Fibrinogen (Factor I)FDA Link 01/2021 - 01/2021
2	von Willebrand FactorIBA 12/2019 - 04/2015
2	LipidsIBA 09/2019 - 01/2019
2	Glutamic Acid (Glutamate)FDA Link 01/2018 - 01/2015
2	ClusterinIBA 01/2017 - 01/2012
2	Small Interfering RNA (siRNA)IBA 01/2017 - 01/2013
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2016 - 01/2011
2	Levodopa (L Dopa)FDA LinkGeneric 08/2015 - 05/2003
2	Serine (L-Serine)FDA Link 06/2015 - 12/2014
2	ZincIBA 01/2014 - 01/2008
2	Free RadicalsIBA 01/2013 - 07/2004
2	Peptide Hydrolases (Proteases)FDA Link 07/2012 - 12/2010
2	PlasminogenIBA 04/2012 - 10/2010
2	Metalloendopeptidases (Metalloendopeptidase)IBA 01/2012 - 01/2008
2	Docosahexaenoic AcidsIBA 03/2010 - 03/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 03/2010 - 03/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2009 - 06/2007
2	Peroxidase (Myeloperoxidase)IBA 10/2008 - 01/2008
2	ParvalbuminsIBA 03/2008 - 10/2005
2	alpha-SynucleinIBA 11/2007 - 01/2003
2	AntibodiesIBA 11/2004 - 04/2002
1	ApolipoproteinsIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Air Pollutants (Pollutants, Air)IBA 02/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021
1	Interleukin-13IBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021

Therapy/Procedure

6	Immunotherapy 01/2019 - 09/2013
4	Therapeutics 12/2020 - 02/2011